Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions.Am J Obstet Gynecol. 2012; 206: 134 e131-138
- Temporal trends in adverse pregnancy outcomes in birthing individuals aged 15 to 44 years in the United States, 2007 to 2019.J Am Heart Assoc. 2022; 11: e025050
- Treatment for mild chronic hypertension during pregnancy.N Engl J Med. 2022; 386 (1533-4406 (Electronic)): 1781-1792
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2018; 138: e484-e594
- Chronic hypertension in pregnancy: ACOG Practice Bulletin Number 203.Obstet Gynecol. 2019; 133: e26-e50
- Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222.Obstet Gynecol. 2020; 135: e237-e260
- Electronic address pso. Society for Maternal-Fetal Medicine Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy-The Chronic Hypertension and Pregnancy trial.Am J Obstet Gynecol. 2022; 227: B24-B27
- Clinical Guidance for the Integration of the Findings of the Chronic Hypertension and Pregnancy (CHAP) Study. ACOG. Practice advisory Web site.(Available at:) (. Published 2022. Updated April 2022. Accessed July 11, 2022)
- Oral antihypertensives for nonsevere pregnancy hypertension: systematic review, network meta- and trial sequential analyses.Hypertension. 2022; 79: 614-628
- Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns.Birth Defects Res B Dev Reprod Toxicol. 2010; 89: 147-154
- The risk of congenital malformations associated with exposure to beta-blockers early in pregnancy: a meta-analysis.Hypertension. 2013; 62: 375-381
- Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.Am J Obstet Gynecol. 2020; 223: 525-537
- Beta-blocker subtypes and risk of low birth weight in newborns.J Clin Hypertens (Greenwich). 2018; 20: 1603-1609
- Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.Ultrasound Med Biol. 2011; 37: 53-58
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.Cochrane Database Syst Rev. 2018; 10: CD002252
- In utero antihypertensive medication exposure and neonatal outcomes: a data linkage cohort study.Hypertension. 2020; 75: 628-633
- Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis.J Obstet Gynaecol Can. 2002; 24: 941-945
- Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes.Am J Obstet Gynecol. 2013; 208: 301 e301-306
- Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy.Pharmacoepidemiol Drug Saf. 2011; 20: 138-145
- The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.Reprod Toxicol. 2008; 26: 24-30
- The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers.Acta Obstet Gynecol Scand. 2001; 80: 397-401
- Effects of diltiazem hydrochloride on embryonic development: species differences in the susceptibility and stage specificity in mice, rats, and rabbits.Okajimas Folia Anat Jpn. 1975; 52: 103-117
- Calcium channel blocker exposure in late pregnancy and the risk of neonatal seizures.Obstet Gynecol. 2015; 126: 271-278
- The effect of nifedipine therapy on fetal and placental Doppler waveforms in preeclampsia remote from term.Am J Obstet Gynecol. 1990; 163: 1844-1848
- Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children.Lancet. 1982; 1: 647-649
- Pregnancy outcome after first trimester use of methyldopa: a prospective cohort study.Hypertension. 2017; 70: 201-208
- Role of antihypertensive treatment and blood pressure control in the occurrence of adverse pregnancy outcomes: a population-based study of linked electronic health records.Hypertension. 2022; 79 (101161HYPERTENSIONAHA12218920): 1548-1558
- Methyldopa as an inductor of postpartum depression and maternal blues: a review.Biomed Pharmacother. 2020; 127: 110196
- Transfer of hydralazine across the placenta and into breast milk.J Obstet Gynaecol. 1986; 7: 47-48
- Severe preeclampsia: is vasodilation therapy with hydralazine dangerous for the preterm fetus?.Am J Perinatol. 1990; 7: 239-244
- Drugs for treatment of very high blood pressure during pregnancy.Cochrane Database Syst Rev. 2013; 7: CD001449
- Overview of randomised trials of diuretics in pregnancy.Br Med J. 1985; 290 (Print): 0267-0623
- The evaluation of the developmental toxicity of hydrochlorothiazide in mice and rats.Fundam Appl Toxicol. 1995; 26: 174-180
- Effects of diuretics on plasma volume in pregnancies with long-term hypertension.Am J Obstet Gynecol. 1984; 150: 831-835
- Diuretics for preventing pre-eclampsia.Cochrane Database Syst Rev. 2007; 1: CD004451
- Placental transfer of hydrochlorothiazide.Gynecol Obstet Invest. 1980; 11: 45-48
- Potassium loss as a causative factor for skeletal malformations in rats produced by indacrinone: a new investigational loop diuretic.Toxicol Appl Pharmacol. 1981; 60: 142-150
- Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants.Early Hum Dev. 2018; 125: 26-30
- Major congenital malformations after first-trimester exposure to ACE inhibitors.N Engl J Med. 2006; 354: 2443-2451
- Cardiac medication during pregnancy, data from the ROPAC.Int J Cardiol. 2014; 177: 124-128
- Angiotensin-converting enzyme inhibitors and the risk of congenital malformations.Obstet Gynecol. 2017; 129: 174-184
- Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review.Hypertension. 2012; 60: 444-450
- Nifedipine or amlodipine? The choice for hypertension during pregnancy: a systematic review and meta-analysis.Arch Gynecol Obstet. 2022; 306: 1891-1900
- Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.Br J Clin Pharmacol. 2018; 84: 1906-1916
- Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.BMJ. 2003; 327: 955-960
- Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis.BJOG. 2016; 123: 40-47
- Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial.Obstet Gynecol. 2013; 122: 1057-1063
- First-line antihypertensive treatment for severe hypertension in pregnancy: a systematic review and network meta-analysis.Pregnancy Hypertens. 2019; 18: 179-187
- Prevalence of hypertensive phenotypes after preeclampsia: a prospective cohort study.Hypertension. 2018; 71: 103-109
- Blood pressure profile 1 year after severe preeclampsia.Hypertension. 2018; 71: 491-498
- Pregnancy and cardiovascular disease.Nat Rev Cardiol. 2020; 17: 718-731
- Postpartum management of hypertensive disorders of pregnancy: a systematic review.BMJ Open. 2017; 7: e018696
- Pharmacotherapy for hypertension in pregnant patients: special considerations.Expert Opin Pharmacother. 2019; 20: 963-982
- Pregnancy-associated changes in pharmacokinetics and their clinical implications.Pharm Res. 2018; 35: 61
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
